References
Note: The figures presented on this page are illustrative examples used to demonstrate current and future trends in the pharmaceutical, cosmetic, and medtech sectors.
They aim to enhance the credibility and objectivity of market analyses. Please refer to the original sources for detailed and contextual information.
Note: The figures presented on this page are illustrative examples used to demonstrate current and future trends in the pharmaceutical, cosmetic, and medtech sectors.
They aim to enhance the credibility and objectivity of market analyses. Please refer to the original sources for detailed and contextual information.
[1] 2018, Drug development success rates are higher than previously reported https://cen.acs.org/articles/96/i7/Drug-development-success-rates-higher.html
[1] 2018, Drug development success rates are higher than previously reported https://cen.acs.org/articles/96/i7/Drug-development-success-rates-higher.html
[2] 2011, The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases , https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149566/
[2] 2011, The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases , https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149566/
[3] 2024, Generative AI Set to Transform the Global Healthcare Market with a 30.1% CAGR by 2030 https://www.globenewswire.com/en/news-release/2024/03/29/2854673/28124/en/Generative-AI-Set-to-Transform-the-Global-Healthcare-Market-with-a-30-1-CAGR-by-2030.html
[3] 2024, Generative AI Set to Transform the Global Healthcare Market with a 30.1% CAGR by 2030 https://www.globenewswire.com/en/news-release/2024/03/29/2854673/28124/en/Generative-AI-Set-to-Transform-the-Global-Healthcare-Market-with-a-30-1-CAGR-by-2030.html